These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 28750624)
1. Leptin OB3 peptide suppresses leptin-induced signaling and progression in ovarian cancer cells. Chin YT; Wang LM; Hsieh MT; Shih YJ; Nana AW; Changou CA; Yang YSH; Chiu HC; Fu E; Davis PJ; Tang HY; Lin HY J Biomed Sci; 2017 Jul; 24(1):51. PubMed ID: 28750624 [TBL] [Abstract][Full Text] [Related]
2. Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin. Yang YC; Chin YT; Hsieh MT; Lai HY; Ke CC; Crawford DR; Lee OK; Fu E; Mousa SA; Grasso P; Liu LF; Chang HY; Tang HY; Lin HY; Davis PJ Oncotarget; 2016 May; 7(19):27641-54. PubMed ID: 27050378 [TBL] [Abstract][Full Text] [Related]
3. Biologically active leptin-related synthetic peptides activate STAT3 via phosphorylation of ERK1/2 and PI-3K. Lin HY; Yang SH; Tang HY; Cheng GY; Davis PJ; Grasso P Peptides; 2014 Jul; 57():95-100. PubMed ID: 24819473 [TBL] [Abstract][Full Text] [Related]
4. Leptin-derived peptides block leptin-induced proliferation by reducing expression of pro-inflammatory genes in hepatocellular carcinoma cells. Ho Y; Wang SH; Chen YR; Li ZL; Chin YT; Yang YSH; Wu YH; Su KW; Chu HR; Chiu HC; Crawford DR; Shih YJ; Grasso P; Tang HY; Lin HY; Davis PJ; Whang-Peng J; Wang K Food Chem Toxicol; 2019 Nov; 133():110808. PubMed ID: 31499123 [TBL] [Abstract][Full Text] [Related]
5. Oral delivery of [D-Leu-4]-OB3 and MA-[D-Leu-4]-OB3, synthetic peptide leptin mimetics: Immunofluorescent localization in the mouse hypothalamus. Anderson BM; Jacobson L; Novakovic ZM; Grasso P Brain Res; 2017 Jun; 1664():1-8. PubMed ID: 28347670 [TBL] [Abstract][Full Text] [Related]
6. The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimulation. Xu X; Dong Z; Li Y; Yang Y; Yuan Z; Qu X; Kong B Int J Biochem Cell Biol; 2013 Mar; 45(3):536-45. PubMed ID: 23262295 [TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor alpha pathway is involved in leptin-induced ovarian cancer cell growth. Choi JH; Lee KT; Leung PC Carcinogenesis; 2011 Apr; 32(4):589-96. PubMed ID: 21173433 [TBL] [Abstract][Full Text] [Related]
8. Bisphenol A induces leptin receptor expression, creating more binding sites for leptin, and activates the JAK/Stat, MAPK/ERK and PI3K/Akt signalling pathways in human ovarian cancer cell. Ptak A; Gregoraszczuk EL Toxicol Lett; 2012 May; 210(3):332-7. PubMed ID: 22343039 [TBL] [Abstract][Full Text] [Related]
9. [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK/6-m db/db mice. Leinung MC; Grasso P Regul Pept; 2012 Nov; 179(1-3):33-8. PubMed ID: 22960403 [TBL] [Abstract][Full Text] [Related]
10. Myristic acid conjugation of [D-Leu-4]-OB3, a biologically active leptin-related synthetic peptide amide, significantly improves its pharmacokinetic profile and efficacy. Novakovic ZM; Anderson BM; Grasso P Peptides; 2014 Dec; 62():176-82. PubMed ID: 25453979 [TBL] [Abstract][Full Text] [Related]
11. c-Jun NH(2)-terminal kinase mediates leptin-stimulated androgen-independent prostate cancer cell proliferation via signal transducer and activator of transcription 3 and Akt. Miyazaki T; Bub JD; Iwamoto Y Biochim Biophys Acta; 2008 Oct; 1782(10):593-604. PubMed ID: 18718531 [TBL] [Abstract][Full Text] [Related]
12. Estrogen-independent role of ERα in ovarian cancer progression induced by leptin/Ob-Rb axis. Ghasemi A; Saeidi J; Mohtashami M; Hashemy SI Mol Cell Biochem; 2019 Aug; 458(1-2):207-217. PubMed ID: 31077012 [TBL] [Abstract][Full Text] [Related]
13. Design of a synthetic leptin agonist: effects on energy balance, glucose homeostasis, and thermoregulation. Rozhavskaya-Arena M; Lee DW; Leinung MC; Grasso P Endocrinology; 2000 Jul; 141(7):2501-7. PubMed ID: 10875251 [TBL] [Abstract][Full Text] [Related]
14. Intranasal delivery of mouse [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, improves energy balance, glycaemic control, insulin sensitivity and bone formation in leptin-resistant C57BLK/6-m db/db mice. Waldrop MA; Leinung MC; Lee DW; Grasso P Diabetes Obes Metab; 2010 Oct; 12(10):871-5. PubMed ID: 20920039 [TBL] [Abstract][Full Text] [Related]
15. Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor α and insulin-like growth factor-1 receptor signaling pathways. Hwang KA; Park MA; Kang NH; Yi BR; Hyun SH; Jeung EB; Choi KC Toxicol Appl Pharmacol; 2013 Nov; 272(3):637-46. PubMed ID: 23933164 [TBL] [Abstract][Full Text] [Related]
16. [D-Leu-4]-OB3, an orally bioavailable leptin-related synthetic peptide insulin sensitizer: a study comparing the efficacies of [D-Leu-4]-OB3 and metformin on energy balance and glycemic regulation in insulin-deficient male Swiss Webster mice. Novakovic ZM; Leinung MC; Grasso P Peptides; 2013 May; 43():167-73. PubMed ID: 23500518 [TBL] [Abstract][Full Text] [Related]
17. The effects of age on uptake, serum half-life and bioavailability of mouse [D-Leu-4]OB3, a synthetic peptide amide with leptin-like activity, in male C57BL/6J mice. Lee DW; Leinung MC; Grasso P Regul Pept; 2008 Oct; 150(1-3):62-5. PubMed ID: 18455249 [TBL] [Abstract][Full Text] [Related]
18. Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells. Cascio S; Ferla R; D'Andrea A; Gerbino A; Bazan V; Surmacz E; Russo A J Cell Physiol; 2009 Oct; 221(1):189-94. PubMed ID: 19492417 [TBL] [Abstract][Full Text] [Related]
19. Assessing the Safety of MA-[D-Leu-4]-OB3, a Synthetic Peptide Leptin Mimetic: Two Pre-Clinical Toxicity Studies in Male and Female C57BL/6 Mice. Enemark F; Novakovic ZM; Grasso P Int J Toxicol; 2023 Dec; 42(6):504-514. PubMed ID: 37556196 [TBL] [Abstract][Full Text] [Related]
20. Leptin signaling in breast cancer: an overview. Cirillo D; Rachiglio AM; la Montagna R; Giordano A; Normanno N J Cell Biochem; 2008 Nov; 105(4):956-64. PubMed ID: 18821585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]